{"id":67937,"date":"2026-06-10T21:32:36","date_gmt":"2026-06-10T13:32:36","guid":{"rendered":"https:\/\/flcube.com\/?p=67937"},"modified":"2026-06-10T21:32:37","modified_gmt":"2026-06-10T13:32:37","slug":"huadong-medicines-ellanse-s-dermal-filler-receives-nmpa-acceptance-for-forehead-contouring-indication-expanding-chinas-premium-aesthetic-portfolio","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=67937","title":{"rendered":"Huadong Medicine&#8217;s Ellans\u00e9 S Dermal Filler Receives NMPA Acceptance for Forehead Contouring Indication, Expanding China&#8217;s Premium Aesthetic Portfolio"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Huadong Medicine Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/000963:SHE\">SHE: 000963<\/a>) announced that the <strong>National Medical Products Administration (NMPA)<\/strong> has accepted for review a market filing for its <strong>injectable polycaprolactone-based dermal filler Ellans\u00e9 S<\/strong>, seeking approval for <strong>forehead contouring<\/strong> in patients with <strong>moderate to severe forehead contour deficiencies<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ellans\u00e9 S, already <strong>NMPA Class III certified since August 2021<\/strong> as the <strong>first imported high-end PCL facial filler<\/strong> in China, is currently indicated for various facial aesthetic applications. The new filing seeks to expand its approved use to include <strong>implantation in the subcutaneous or subperiosteal layer of the forehead<\/strong>, addressing a significant unmet need in the premium aesthetic market.<\/p>\n\n\n\n<h2 id=\"h-product-profile-amp-technology-platform\" class=\"wp-block-heading\">Product Profile &amp; Technology Platform<\/h2>\n\n\n\n<h3 id=\"h-dual-action-mechanism\" class=\"wp-block-heading\">Dual-Action Mechanism<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Immediate Effect<\/strong>: Carboxymethylcellulose (CMC)-based gel carrier provides rapid filling and instant contouring<\/li>\n\n\n\n<li><strong>Long-Term Benefit<\/strong>: Polycaprolactone (PCL) microspheres stimulate new collagen production at injection site<\/li>\n\n\n\n<li><strong>Natural Results<\/strong>: Collagen scaffold restoration delivers natural-looking, long-lasting aesthetic improvement<\/li>\n\n\n\n<li><strong>Biocompatibility<\/strong>: Both PCL and CMC components demonstrate excellent safety profiles with minimal adverse reactions<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-product-specifications\" class=\"wp-block-heading\">Product Specifications<\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Component<\/th><th>Function<\/th><th>Duration<\/th><\/tr><\/thead><tbody><tr><td><strong>CMC Gel Carrier<\/strong><\/td><td>Immediate volume restoration<\/td><td>Temporary (weeks-months)<\/td><\/tr><tr><td><strong>PCL Microspheres<\/strong><\/td><td>Collagen stimulation<\/td><td>Long-lasting (up to 2 years)<\/td><\/tr><tr><td><strong>Particle Size<\/strong><\/td><td>Optimized for forehead tissue<\/td><td>Precision-engineered<\/td><\/tr><tr><td><strong>Injection Depth<\/strong><\/td><td>Subcutaneous or subperiosteal<\/td><td>Anatomically appropriate<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-regulatory-status-amp-global-presence\" class=\"wp-block-heading\">Regulatory Status &amp; Global Presence<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Current China Status<\/strong>: NMPA Class III medical device certification (August 2021)<\/li>\n\n\n\n<li><strong>New Filing<\/strong>: Forehead contouring indication under NMPA review<\/li>\n\n\n\n<li><strong>Global Registration<\/strong>: Approved in <strong>60+ countries\/regions<\/strong> worldwide<\/li>\n\n\n\n<li><strong>Market Position<\/strong>: First imported high-end PCL filler in Chinese market<\/li>\n\n\n\n<li><strong>Device Classification<\/strong>: Category III (highest risk classification for medical devices)<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-opportunity-amp-competitive-landscape\" class=\"wp-block-heading\">Market Opportunity &amp; Competitive Landscape<\/h2>\n\n\n\n<h3 id=\"h-chinese-aesthetic-market-dynamics\" class=\"wp-block-heading\">Chinese Aesthetic Market Dynamics<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Market Size<\/strong>: China&#8217;s dermal filler market projected to reach $2.5 billion by 2028<\/li>\n\n\n\n<li><strong>Premium Segment Growth<\/strong>: High-end fillers growing at 25% CAGR, outpacing overall market<\/li>\n\n\n\n<li><strong>Forehead Aesthetics<\/strong>: Emerging as key treatment area with limited specialized product options<\/li>\n\n\n\n<li><strong>Consumer Preference<\/strong>: Increasing demand for natural-looking, long-lasting results over temporary solutions<\/li>\n<\/ul>\n\n\n\n<h3 id=\"h-competitive-advantages\" class=\"wp-block-heading\">Competitive Advantages<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Dual-Action Technology<\/strong>: Unique combination of immediate results with long-term collagen stimulation<\/li>\n\n\n\n<li><strong>Safety Profile<\/strong>: Excellent biocompatibility reduces risk of adverse events compared to permanent fillers<\/li>\n\n\n\n<li><strong>Duration Advantage<\/strong>: Longer-lasting results (up to 24 months) versus hyaluronic acid fillers (6-18 months)<\/li>\n\n\n\n<li><strong>First-Mover Status<\/strong>: Established market presence as first imported PCL filler in China<\/li>\n\n\n\n<li><strong>Indication Expansion<\/strong>: Forehead approval would provide competitive differentiation in underserved anatomical area<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-commercial-strategy-amp-revenue-impact\" class=\"wp-block-heading\">Commercial Strategy &amp; Revenue Impact<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Target Practitioners<\/strong>: High-end aesthetic clinics and specialized dermatology practices<\/li>\n\n\n\n<li><strong>Pricing Position<\/strong>: Premium pricing reflecting advanced technology and extended duration<\/li>\n\n\n\n<li><strong>Training Programs<\/strong>: Comprehensive physician education on forehead-specific injection techniques<\/li>\n\n\n\n<li><strong>Market Penetration<\/strong>: Leverage existing distribution network and brand recognition<\/li>\n\n\n\n<li><strong>Revenue Contribution<\/strong>: Analysts project $50-80 million in peak annual sales for forehead indication in China<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">This regulatory filing represents Huadong Medicine&#8217;s strategic expansion of its premium aesthetic portfolio, capitalizing on growing consumer demand for sophisticated, long-lasting facial rejuvenation solutions in China&#8217;s rapidly evolving beauty market.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward-Looking Statements<\/strong><br>This brief contains forward-looking statements regarding regulatory approvals, market adoption, competitive positioning, and revenue projections. Actual results may differ due to regulatory decisions, market competition, and evolving consumer preferences.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/\u534e\u4e1c\u533b\u836f\uff1a\u5173\u4e8e\u5168\u8d44\u5b50\u516c\u53f8\u6536\u5230\u533b\u7597\u5668\u68b0\u6ce8\u518c\u7533\u8bf7\u53d7\u7406\u901a\u77e5\u4e66\u7684\u516c\u544a.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u534e\u4e1c\u533b\u836f\uff1a\u5173\u4e8e\u5168\u8d44\u5b50\u516c\u53f8\u6536\u5230\u533b\u7597\u5668\u68b0\u6ce8\u518c\u7533\u8bf7\u53d7\u7406\u901a\u77e5\u4e66\u7684\u516c\u544a.\"><\/object><a id=\"wp-block-file--media-8fa3f8f4-addc-4367-a3a7-df2b62d917f8\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/\u534e\u4e1c\u533b\u836f\uff1a\u5173\u4e8e\u5168\u8d44\u5b50\u516c\u53f8\u6536\u5230\u533b\u7597\u5668\u68b0\u6ce8\u518c\u7533\u8bf7\u53d7\u7406\u901a\u77e5\u4e66\u7684\u516c\u544a.pdf\">\u534e\u4e1c\u533b\u836f\uff1a\u5173\u4e8e\u5168\u8d44\u5b50\u516c\u53f8\u6536\u5230\u533b\u7597\u5668\u68b0\u6ce8\u518c\u7533\u8bf7\u53d7\u7406\u901a\u77e5\u4e66\u7684\u516c\u544a<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/06\/\u534e\u4e1c\u533b\u836f\uff1a\u5173\u4e8e\u5168\u8d44\u5b50\u516c\u53f8\u6536\u5230\u533b\u7597\u5668\u68b0\u6ce8\u518c\u7533\u8bf7\u53d7\u7406\u901a\u77e5\u4e66\u7684\u516c\u544a.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-8fa3f8f4-addc-4367-a3a7-df2b62d917f8\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Huadong Medicine Co., Ltd. (SHE: 000963) announced that the National Medical Products Administration (NMPA) has&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,22],"tags":[114,38,100,887],"class_list":["post-67937","post","type-post","status-publish","format-standard","hentry","category-company","category-medical-device","tag-huadong-medicine","tag-market-approval-filings","tag-medical-aesthetics","tag-she-000963"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Huadong Medicine&#039;s Ellans\u00e9 S Dermal Filler Receives NMPA Acceptance for Forehead Contouring Indication, Expanding China&#039;s Premium Aesthetic Portfolio - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Huadong Medicine Co., Ltd. (SHE: 000963) announced that the National Medical Products Administration (NMPA) has accepted for review a market filing for its injectable polycaprolactone-based dermal filler Ellans\u00e9 S, seeking approval for forehead contouring in patients with moderate to severe forehead contour deficiencies.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=67937\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Huadong Medicine&#039;s Ellans\u00e9 S Dermal Filler Receives NMPA Acceptance for Forehead Contouring Indication, Expanding China&#039;s Premium Aesthetic Portfolio\" \/>\n<meta property=\"og:description\" content=\"Huadong Medicine Co., Ltd. (SHE: 000963) announced that the National Medical Products Administration (NMPA) has accepted for review a market filing for its injectable polycaprolactone-based dermal filler Ellans\u00e9 S, seeking approval for forehead contouring in patients with moderate to severe forehead contour deficiencies.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=67937\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-10T13:32:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-10T13:32:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67937#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67937\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Huadong Medicine&#8217;s Ellans\u00e9 S Dermal Filler Receives NMPA Acceptance for Forehead Contouring Indication, Expanding China&#8217;s Premium Aesthetic Portfolio\",\"datePublished\":\"2026-06-10T13:32:36+00:00\",\"dateModified\":\"2026-06-10T13:32:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67937\"},\"wordCount\":504,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Huadong Medicine\",\"Market approval filings\",\"Medical aesthetics\",\"SHE: 000963\"],\"articleSection\":[\"Company\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67937#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67937\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=67937\",\"name\":\"Huadong Medicine's Ellans\u00e9 S Dermal Filler Receives NMPA Acceptance for Forehead Contouring Indication, Expanding China's Premium Aesthetic Portfolio - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-06-10T13:32:36+00:00\",\"dateModified\":\"2026-06-10T13:32:37+00:00\",\"description\":\"Huadong Medicine Co., Ltd. (SHE: 000963) announced that the National Medical Products Administration (NMPA) has accepted for review a market filing for its injectable polycaprolactone-based dermal filler Ellans\u00e9 S, seeking approval for forehead contouring in patients with moderate to severe forehead contour deficiencies.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67937#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=67937\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=67937#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Huadong Medicine&#8217;s Ellans\u00e9 S Dermal Filler Receives NMPA Acceptance for Forehead Contouring Indication, Expanding China&#8217;s Premium Aesthetic Portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Huadong Medicine's Ellans\u00e9 S Dermal Filler Receives NMPA Acceptance for Forehead Contouring Indication, Expanding China's Premium Aesthetic Portfolio - Insight, China&#039;s Pharmaceutical Industry","description":"Huadong Medicine Co., Ltd. (SHE: 000963) announced that the National Medical Products Administration (NMPA) has accepted for review a market filing for its injectable polycaprolactone-based dermal filler Ellans\u00e9 S, seeking approval for forehead contouring in patients with moderate to severe forehead contour deficiencies.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=67937","og_locale":"en_US","og_type":"article","og_title":"Huadong Medicine's Ellans\u00e9 S Dermal Filler Receives NMPA Acceptance for Forehead Contouring Indication, Expanding China's Premium Aesthetic Portfolio","og_description":"Huadong Medicine Co., Ltd. (SHE: 000963) announced that the National Medical Products Administration (NMPA) has accepted for review a market filing for its injectable polycaprolactone-based dermal filler Ellans\u00e9 S, seeking approval for forehead contouring in patients with moderate to severe forehead contour deficiencies.","og_url":"https:\/\/flcube.com\/?p=67937","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-06-10T13:32:36+00:00","article_modified_time":"2026-06-10T13:32:37+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=67937#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=67937"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Huadong Medicine&#8217;s Ellans\u00e9 S Dermal Filler Receives NMPA Acceptance for Forehead Contouring Indication, Expanding China&#8217;s Premium Aesthetic Portfolio","datePublished":"2026-06-10T13:32:36+00:00","dateModified":"2026-06-10T13:32:37+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=67937"},"wordCount":504,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Huadong Medicine","Market approval filings","Medical aesthetics","SHE: 000963"],"articleSection":["Company","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=67937#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=67937","url":"https:\/\/flcube.com\/?p=67937","name":"Huadong Medicine's Ellans\u00e9 S Dermal Filler Receives NMPA Acceptance for Forehead Contouring Indication, Expanding China's Premium Aesthetic Portfolio - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-06-10T13:32:36+00:00","dateModified":"2026-06-10T13:32:37+00:00","description":"Huadong Medicine Co., Ltd. (SHE: 000963) announced that the National Medical Products Administration (NMPA) has accepted for review a market filing for its injectable polycaprolactone-based dermal filler Ellans\u00e9 S, seeking approval for forehead contouring in patients with moderate to severe forehead contour deficiencies.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=67937#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=67937"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=67937#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Huadong Medicine&#8217;s Ellans\u00e9 S Dermal Filler Receives NMPA Acceptance for Forehead Contouring Indication, Expanding China&#8217;s Premium Aesthetic Portfolio"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67937","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=67937"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67937\/revisions"}],"predecessor-version":[{"id":67939,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/67937\/revisions\/67939"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=67937"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=67937"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=67937"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}